Showing results (21-30 of 75) with videos related to
Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|May 17, 2011
Preclinical in vitro and in vivo evaluation of the potent and specific cyclin-dependent kinase 2 inhibitor NU6102 and a water soluble prodrug NU6301Huw D Thomas, Lan-Zhen Wang, Celine Roche, et al.Journal of Medicinal Chemistry|March 4, 2011
Nucleoside transport inhibitors: structure-activity relationships for pyrimido[5,4-d]pyrimidine derivatives that potentiate pemetrexed cytotoxicity in the presence of α1-acid glycoproteinKappusamy Saravanan, Hannah C Barlow, Marion Barton, et al.Leukemia Research|February 15, 2011
Comparative pre-clinical evaluation of receptor tyrosine kinase inhibitors for the treatment of multiple myelomaLuis R de Brito, Mike A Batey, Yan Zhao, et al.Journal of the National Cancer Institute|May 8, 2003
2-[11C]thymidine positron emission tomography as an indicator of thymidylate synthase inhibition in patients treated with AG337Paula Wells, Eric Aboagye, Roger N Gunn, et al.Journal of the American Chemical Society|May 4, 2006
Searching for cyclin-dependent kinase inhibitors using a new variant of the cope eliminationRoger J Griffin, Andrew Henderson, Nicola J Curtin, et al.Chemical Science|June 30, 2017
Design and synthesis of biphenyl and biphenyl ether inhibitors of sulfatasesTristan Reuillon, Sari F Alhasan, Gary S Beale, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Novel poly(ADP-ribose) polymerase-1 inhibitor, AG14361, restores sensitivity to temozolomide in mismatch repair-deficient cellsNicola J Curtin, Lan-Zhen Wang, Anthie Yiakouvaki, et al.British Journal of Cancer|August 26, 2016
Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinomaSari F Alhasan, Beate Haugk, Laura F Ogle, et al.Organic & Biomolecular Chemistry|May 8, 2010
Synthesis and biological evaluation of 5-substituted O4-alkylpyrimidines as CDK2 inhibitorsFrancesco Marchetti, Céline Cano, Nicola J Curtin, et al.Cancer Research|May 19, 2006
Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441Yan Zhao, Huw D Thomas, Michael A Batey, et al.Pageof 8